ABSTRACT
INTRODUCTION
Eukaryotic nuclei contain three RNA polymerases (I, II, III) 1, 2 , which are part of larger complexes; for example, RNA polymerase II is found with enzymatic activities involved in initiation, capping, splicing, and poly-adenylation 3, 4 . These complexes may be organized into even larger structures that harbor most of the machinery required for transcript production known as "transcription factories" 5, 6 . These are typically defined as sites containing at least two different active transcription units (simply to distinguish them from the case where two polymerizing complexes are active on one template), and harbor more than 95% of total transcriptional activity in a mammalian cell 5 . The biochemical isolation of such factories would allow dissection of the protein content of the active sites of transcription, and most nascent transcripts being produced at any given moment. However, their isolation has proved challenging due to their large mass and tight association with nuclear substructures.
Furthermore, the failure to isolate transcription factories had raised concerns as to whether factories actually exist 7 . A few years ago we addressed these issues by introducing an approach for purifying large fragments of factories with an apparent mass of >8 MDa (the size of the largest protein marker commercially available), and went on to analyze the proteomes of different complexes containing either polymerase I, or II, or III 8 . More recently we adapted this method to catalogue their RNA content revealing a strong enrichment for nascent transcripts 9 . Here, we present a protocol for a unified workflow to purify protein and/or RNA from transcription factories based on the combination of both procedures (Fig. 1) .
Overview of the method and its applications
There is a long-standing research interest in complexes involved in the regulation of gene expression, and a growing volume of literature points to transcription factories as important contributors in this (reviewed in ref. 5 ). Until recently, neither the protein composition of factories nor their primary products -the nascent, factory-associated, transcripts -could be directly interrogated.
Two factors make purification of mammalian polymerases engaged on endogenous templates difficult. First, active enzymes represent only a quarter of the total; the remaining majority form a rapidly-diffusing soluble pool that tends to aggregate in non-isotonic buffers 8, 10, 11 . Therefore, we use isotonic conditions whilst removing the inactive fraction. Second, engaged polymerases plus their templates and transcripts are housed in factories bound to the underlying nuclear scaffold 8, [10] [11] [12] .
As caspases deconstruct nuclei during apoptosis, we reasoned they might be used to also release factories. In brief, the method relies on the isolation of nuclei from living (unfixed) cells in close-tophysiological salt concentrations. Then, the most chromatin is detached by DNase I, and factories are disengaged from the nuclear substructure using a mixture of group-III caspases. After pelleting nuclear debris, large fragments of the factories (>8 MDa) are found in the supernatant. Once the RNA and/or the proteins in this supernatant have been purified (see Fig. 1 ), high-throughput sequencing of RNA and/or mass-spectrometry can be applied to comprehensively catalogue factory content 8, 9 .
Overall, the current protocol is reproducible, straightforward to implement, and requires limited hands-on time. The whole process concludes in less than 72 hours (not including the time needed for mass-spectrometry or next-generation sequencing) and is particularly suited to dissect cellular responses to extra-cellular cues. For example, one could monitor the changes in the protein and RNA content of the active transcription compartment when transcription is reprogrammed by different cytokines.
Limitations of the method and comparison to existing approaches
Although the content of mature and nascent proteins in large subcellular complexes like nucleoli have been analyzed 13, 14 , factory-associated proteins have been difficult to interrogate. While our method facilitates proteomic analysis of isolated factories ( Fig. 1) , it still requires large numbers of cells (in the order of ~5x10 7 ), especially if the three polymerizing activities are to be separated by 2D electrophoresis 8 . In addition, caspase treatment inevitably hinder the detection of those proteins that are most targeted by the enzymes used.
Similarly, there exist many methods for isolating and characterizing newly-synthesized RNA, for example "GRO-seq" 15 , "mNET-seq" 16, 17 , "chromatin RNA-seq" 18 , "poly(A)-depleted RNA-seq" 19 , "nascent-seq" 20 , and the metabolic tagging of newly-made RNA using 4-thiouridine 21, 22 . Each of these has its own particular shortcomings, and all are relatively laborious and/or require a high sequencing depth; most also focus on particular parts of the transcriptome (for a comparison of RNA-seq methods, see Table 1 ). Hence, cataloguing nascent mammalian transcriptomes is challenging (in contrast to the now-routine mapping of mRNAs) due to the short half-lives, low abundance, and variety of processing pathways. Nonetheless, such cataloguing can be highly informative, especially when analyzing short-term responses to stimuli, and the associated changes in messenger, non-coding, and enhancer RNAs (eRNAs 23, 24 ). Analysis of factory-associated transcripts offers a simple, low-cost, way for assessing transcriptional changes at the level of nascent RNA. However, the current approach uses freshly-isolated cells, and analogous methods for fixed cells have yet to be developed.
Nevertheless, eRNAs (and other short-lived transcripts) can be detected with high sensitivity (see ref.
9 for an example) and most chromatin-associated RNA can be studied as a separate fraction, despite factory-and chromatin-associated fractions inevitably sharing components.
Experimental design
As already noted, the isolation of transcription factories is performed on living cells collected in a "physiological" buffer. Although, labeling nascent RNA is not required, this may be included (see Fig. 2 ), especially when setting up the technique to quantitate retention of transcriptional activity and nascent RNA (Box 1).
Then, cells are permeabilized using saponin, polymerases allowed to extend their transcripts (by "running-on") by <40 nucleotides in a tagged precursor (e.g., Br-UTP or [ 32 P]UTP), and the amount of label incorporated into RNA measured (e.g., using anti-BrU antisera and immunofluorescence, or autoradiography/scintillation counting 8 ). After the run-on, nuclei are isolated and chromatin is digested with DNase I to release most chromatin into the supernatant. Nuclei are still largely intact at this stage. They are now resuspended in a "native lysis buffer" and digested with caspases 6, 8, 9, and 10 (core subunits of the three RNA polymerases lack sites recognized by these caspases, with the exception of RPB9). After stopping the reaction, the sample can be retreated with DNase I (to trim off as much chromatin as possible). After repelleting, the resulting supernatant contains large (>8-MDa) fragments of factories, and its contents can be analyzed in various ways to fit the needs of each enduser.
For proteomic studies, released complexes can be resolved electrophoretically using a "native" (preparative) two-dimensional acrylamide-agarose composite gel; the three polymerizing activities are separated into partially-overlapping regions of the gel. To trace the positions of the complexes containing the different RNA polymerases and verify separation, additional small aliquots of the same sample from the same preparation are separated in a set of identical (analytical) minigels. For transcriptome analysis, RNA is isolated from the factory-containing supernatant using
Trizol, and cDNA libraries prepared for next-generation sequencing (in our case, on an Illumina platform; Box 3). For such an analysis, significantly lower cell counts can be used, and robust coverage of mRNAs and eRNAs can be achieved using as few as 0.5x10 6 cells (M.C.-H., K.R. and A.P.,
unpublished data).
A sequencing depth of ~35 million reads suffices to catalogue comprehensively factory-associated RNAs, including long non-coding (lncRNAs) and eRNAs from ~10 million cells 9 . It is noteworthy that in the course of isolating factories, additional fractions can easily be retained at the appropriate stages to provide "total cell", "cytoplasmic", "nuclear", and "chromatin-associated" ones (Fig. 1) ; subsequent comparison of their contents can provide additional insight into the organization of mammalian transcription along the genome.
• RestorePlus™ Western Blot Stripping buffer (Thermo Scientific, cat. no. PI46428)
• Saponin (Sigma-Aldrich, cat. no. 47036)
• SeaKem® Gold Agarose (Lonza, cat. no. 50152)
• Sodium dodecyl-sulphate (SDS; Sigma-Aldrich, cat. no. L3771)
• Sucrose (Sigma-Aldrich, cat. no. S0389)
• SuperSignal™ West Pico ECL detection kit (Pierce, cat. no. PI34081)
• SYBR Green II nucleic acids gel stain (Life Technologies, cat. no. S33102)
• Tetra-methyl-ethylenediamine (TEMED; SigmaAldrich, cat. no. T22500)
• Tris (Sigma-Aldrich, cat. no. T1503)
• Triton X-100 (Sigma-Aldrich, cat. no. T8787)
• Trizol® LS (Life Technologies, cat. no. 10296-010) ! CAUTION: Trizol-based solutions are toxic and must be handled and disposed of according to established national and institutional regulations.
• Tween-20 (Sigma-Aldrich, cat. no. P9416)
• Whatman® filter paper, Grade 1 (Sigma-Aldrich, cat. no. Z240087)
• Xylene cyanol (Sigma-Aldrich, cat. no. X4126)
Enzymes/inhibitors:
• Active human caspases, Group III (6-,8-,9-,10) mix (BioCat, cat. no. K243-4-25-BV)
• Complete protease inhibitor cocktail, EDTA-free (PIC; Roche, cat. no. 6538282001)
• DNase I (Worthington, cat. no. LS006331) CRITICAL: If another brand is used, check for enzyme activity in PB.
• Group-III caspase inhibitor (Calbiochem, cat. no.
2188745)
• Proteinase K (Roche, cat. no. 3115828001)
• RNase inhibitor (RiboLock; Thermo Scientific, cat. no. E00384)
Antibodies:
• Chicken polyclonal anti-RPC62 (Abcam, cat. no. ab26185; used at 1/1000 dilution )
• Mouse monoclonal anti-RPA194 (Santa-Cruz Biotech., cat. no. sc-48385; used at 1/100 dilution)
• Mouse monoclonal anti-RPB1 (7C2 27 , used at 1/10,000 dilution).
EQUIPMENT
• Cooling microcentrifuge (Hermel, cat. no. Z216MK) • iBlot™ dry blotting system (Life Technologies, cat.
no. IB1001)
• Mini-Protean3® electrophoresis cell (Bio-Rad, cat.no. 1658000)
• Nanodrop spectrophotometer (LabTech, ND-1000)
• Protean II xi® electrophoresis cell (Bio-Rad, cat. no.
1651801)
• Thermomixer (HLC, cat. no. DITA15001)
REAGENT SETUP CRITICAL STEP: Prepare all solutions using Milli-Q H 2 O (Millipore) or DEPC-treated water in glassware decontaminated by baking (>180°C, overnight) or in nuclease-free plasticware.
Complete protease inhibitor, EDTA-free (PIC). Dissolve one tablet in 1 ml of PBS to create a 50× working solution. Store the solution at 20°C for up to 3 months; avoid repeated freeze-thaw cycles. sucrose, 0.05% Triton X-100. Stored at 4°C for a maximum of 6 months.
10x Composite gel running buffer: 400 mM Tris-acetate (pH 7.4).
Coomassie solution: 500 mM 6-aminocaproic acid, 2% (w/v) Coomassie Blue G-250. Stored at 4°C for a maximum of 6 months.
TBS-T buffer:
50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.05% Tween-20.
10x Tris-glycine running buffer: 250 mM Tris (pH 8.3), 1.92 M glycine, 1% SDS. Glycine stocks should be stored at 4°C for a maximum of 6 months.
Starting material:
The protocol is implemented on living cells, either grown in suspension or as a monolayer. Cells grown in suspension ensure fewer losses as they do not need to be scraped or trypsinized off the surface. We typically start with 5x10 7 cells for proteomic analyses, and 4-8x10 6 cells for nascent RNA sequencing (see Fig. 3 for some data on use of lower cell counts).
PROCEDURE Preparation of cells TIMING: 1 h 1|
The protocol is implemented on living cells grown in suspension or as a monolayer. If DNA recovery needs to be monitored, scintillation counting can be used; add 0.25 Ci/ml [methyl- 3 H]thymidine to the culture medium a day before to achieve uniform labeling by incorporation into cellular DNA 8 . Harvest cells according to either option A or B.
A For cells grown as a monolayer on 15-cm culture dishes (e.g., HUVECs 9 ):
i Split cells the day before the experiment. Harvest them when they reach 75-85%
confluence.
ii Aspirate medium from plates, and immediately place them on ice.
iii Add 2.5 ml of ice-cold PB per plate. Gently scrape cells and transfer to a 50-ml falcon tube. CRITICAL STEP: Soft rubber scrapers are strongly recommended.
iv Collect cells by centrifugation at 400 x g for 5 min at 4°C; keep pellets on ice.
B For cells grown in suspension (e.g., HeLa in spinner culture 8 ):
i Collect cells by centrifugation at 400 x g for 5 min at 4°C.
ii Remove medium, immediately place cells on ice. 3| Pellet nuclei at 400 x g for 5 min at 4°C, and remove the supernatant.
4|
Wash briefly once more in PB+0.4% NP-40, and pellet as above.
5|
Gently resuspend pellet in PB+0.4% NP-40 supplemented with 0.5 mM CaCl 2 (100 l/10 7 cells), and transfer to a 2-ml tube.
CRITICAL STEP: From this step onwards use 2-ml round-bottom (nuclease-free) tubes.
6|
Add DNase I (10 units/10 7 cells) and incubate for 30 min at 33°C.
CRITICAL STEP:
No shaking at this step.
? TROUBLESHOOTING (see Table 2) 7| Stop the reaction by adding EDTA to 2.5 mM and cooling on ice. A small aliquot (depending on the starting amount of cells) can be kept here and used to isolate DNA, and verify the extent of DNA fragmentation by DNase I (a smear around ~200 bp is expected; see Fig. 4a ).
? TROUBLESHOOTING 8| Spin digested nuclei at 600 x g for 5 min at 4°C, keep both the supernatant and pellet separately. 11| Add the caspases to the sample (2 units of caspases mix/10 7 nuclei) and incubate at 33°C for 30 min in a thermomixer with vigorous (~900 rpm) shaking.
12|
Transfer on ice and stop the reaction by adding group-III caspase inhibitor to a final concentration of 0.2 mM (we typically use a 20 mM stock which is stored at -20°C).
13| Following a brief incubation on ice, spin at 600 x g for 5 min at 4°C.
14|
Collect supernatant and treat it with DNase I as before (steps 7-8); this is the fraction that contains large fragments of factories. The quality of the large fragments can be assessed by performing 2D native electrophoresis in (small) analytical gels (Box 2). From this point onwards proceed according to either option A or B.
A For analysis of factory-associated RNA:
i Directly mix the supernatant with 0.75-1 ml Trizol and allow the sample to sit at room temperature (22°C) for 5 min.
ii Now RNA is purified directly or the Trizol mix is stored at -80°C. Once RNA is purified, strand-specific cDNA libraries may be prepared as described (Box 3).
B For proteomic analysis proceed with steps 16-26.
PAUSE POINT: Samples can be aliquoted, snap-frozen in liquid nitrogen, and stored at -80°C.
? TROUBLESHOOTING Native 2D electrophoresis, preparative TIMING: 36-48 h
Conditions for electrophoresis in a native 2D gel are modified from those used previously 28, 29 .
15| Cast 1 st dimension gel (0.7% agarose, 1.5% acrylamide in 40 mM Tris-acetate pH 7.4, 7% sucrose, 0.01% Triton X-100) for example using the Protean II® xi system (gel dimensions of 16 x 20 x 0.15 cm) using 1.5 mm a 5-well wide-tooth comb (Bio-Rad). Assemble the casting plates and measure the exact amount of water needed for one such gel, and prepare as follows (example for a 10-ml gel is given; scale amounts up proportionately for larger gel volumes):
0.07 g (in 7.425 ml water) 0.7% Acrylamide (30%; 37.5:1) 0.5 ml 1.5% Composite gel buffer (5x) 2.0 ml 1x TEMED (100% w/v) 15 µl 0.15% APS (25% w/v) 60 µl 0.15% Total 10 ml CRITICAL STEP: Weigh the 0.07 g of agarose in a glass beaker, add 7.425 ml of Milli-Q water and weigh the beaker before melting the agarose in a microwave oven. After slowly bringing the gel to boiling, weigh the beaker again and add back the amount of water that evaporated. Also, preheat the casting plates to 37°C before pouring the gel. Pour the gel and allow it to polymerize at room temperature for 1 hour before the run.
16|
Load the preparative gels with a sample equivalent to that isolated from 4-5x10 7 cells (not radioactively labeled). Bromophenol blue (0.004% w/v) and xylene cyanol (0.004% w/v) are added to the sample to monitor migration. Then, for separating/isolating complexes containing RNA polymerases II and III, add Coomassie blue solution to the sample (1/1000 dilution) to be loaded onto the gel, incubate sample for 30 min on ice, and add Coomassie solution into the 1x cathode buffer at a 1/100 dilution. For the separation/isolation of complexes containing RNA polymerases I (nucleolar factories), do not add Coomassie (as it affects migration of the RNAPI complex); hence, proceed directly to sample loading.
Note:
It is also possible to proceed directly to mass-spectrometry of the supernatant isolated in step 14, without separating the different RNA polymerase-containing complexes by 2D electrophoresis.
Such an approach can reduce the starting amount of cells required for analysis, and it is the enduser's decision which variation of the protocol best fits the question in hand.
17|
Load the sample onto the 1 st dimension gel. Use Blue carrier protein (200 ng in NLB with 1/1000
Coomassie solution) as a protein marker (8 MDa).
18|
Run the gel at a constant voltage of 100 V in 1x composite running buffer until the sample has fully entered the gel. Then reduce to 40 V and electrophorese overnight in a cold room. At the end of the run, xylene cyanol has migrated ~¾ of the length of the gel and bromophenol blue is lost.
19|
Following electrophoresis, cut a sample-containing strip out of the gel using a clean scalpel. 
CRITICAL STEP:
In order to avoid excessive contamination by skin keratin it is advisable to handle all related equipment and consumables while wearing gloves.
TIMING
The two legs of this protocol are variably timed, but the core is common to both (steps 1-14) and concludes within less than a day and requires little hands-on time. The transcriptomics leg is also not laborious; it requires standard RNA isolation, followed by the preparation of cDNA libraries for highthroughput sequencing (Box 3). Then, depending on the sequencing facility of choice, the turnaround times may vary. As regards the proteomics leg, analysis by native 2D electrophoresis is quite laborious, and may prove even more so for inexperienced users. However, if the separation of complexes belonging to each of the three RNA polymerases is not required, then the factory fraction obtained by step 14 can be essentially directly analyzed by mass-spectrometry. Nonetheless, for both legs it is important to devote some time to quality controls using either RT-qPCR (Box 3) or Western blots (Box 2); these should take place after obtaining the factory fraction and before proceeding to downstream high-throughput analyses of either kind. Of course, addition of a "run-on" (Box 1) may prove helpful at the beginning, without dramatically increasing the total time required.
ANTICIPATED RESULTS
This protocol results in the cataloguing of RNA and proteins associated with transcription factories.
Depending on the desired end-point analysis, anticipated results and necessary controls differ.
For high-throughput sequencing of HUVEC factory RNA we previously performed an analysis using standard bioinformatic tools 9 . In brief, we mapped the resulting 100-bp reads, reported as a ".fastq" file, to the human genome (reference build GRCh37/hg19) using Bowtie 30 and default parameters. Reassuringly <10% of mapped reads mapped to rDNA regions, and these reads were excluded from downstream analyses. The Integrative Genomics Viewer (www.broadinstitute.org/igv) was used to visualize genomic coverage, transcripts were assembled using Cufflinks 31 and annotated via the Genomatix software suite (Genomatix). It should be noted here that there now exist dedicated in silico pipelines 32, 33 for assessing changes in gene expression based on intronic RNA levels (instead of exonic levels that standard algorithms use), and we anticipate that their implementation will further enhance the sensitivity of factory RNA-seq.
It is also recommended to perform side-by-side analysis of the factory and total or poly(A)-enriched RNA-seq datasets from the same cell type and set of conditions. Typically factory RNA-seq returns read profiles that are rich in intronic signal (Fig. 4b-d) . The expected read distribution, compared to poly(A)-enriched RNA, for example, should show marked depletion in exonic reads with a concomitant enrichment of reads mapping to introns, intron-exon junctions, and intergenic space (Fig. 4c) . A key advantage of our method is the detection of eRNAs produced at active enhancers, despite them being so unstable. Here, detection sensitivity (as exemplified using a set of ~1300 active intergenic enhancers 9 in Fig. 4e ) is superior to that achieved by total (ribodepleted) or chromatin RNA-seq.
For proteomics analyses, depending on the instrument used and the implementation of metabolic protein labeling 25 , results will vary. Here, we present an exemplary analysis on isolated
HeLa factory complexes for all three polymerase as a guide (from ref. 8). After resolving complexes on native 2D gels (Fig. 5a,b) , each sample was excised as a single gel piece, proteins analyzed by SDS-PAGE and trypsin-treated, and the now-separated peptides extracted, vacuum dried, and injected (typically three injections/sample; 120 min/injection) into a Dionex U3000 nanoHPLC system coupled to an LTQ Orbitrap mass spectrometer (Thermo Scientific). The three resulting data files were merged, converted to ".mzXML" format and submitted to the Central Proteomics Facilities pipeline 34 .
This pipeline uses a combination of search engines and scores, and sorts peptides hits using the integrated iProphet toolkit 35 . Then, predictions are validated by comparison to a concatenated target-decoy database (International Protein Index human v3.64) to return the final protein lists with <1% false discovery rate (FDR; empirical). As a further test, we also generate protein lists using a more stringent 0.5% FDR cutoff; these should typically contain 90% of proteins predicted using the 1% FDR cutoff. Biological replicates of the above are expected to display 75% overlap in the proteins identified (full data from ref. 8 in: http://users.path.ox.ac.uk/~pcook/data/ContentOfFactories.html).
Note that we chose to apply the "normalized spectral index" approach 36 to our data to estimate relative protein abundancies, in the absence of metabolic labeling. . 5c ). Finally, in order to determine the Gene Ontology (GO) terms that concisely describe the contents of each factory complex, we produced the "MS-prot" algorithm (freely-available at http://www.ms-prot.co.uk/) that connects a given UniProt accession number to all associated GO terms, and allows user-defined GO term groups to be used as a filter. Then, when factory-associated GO terms are compared to those associated with terms like "cytoplasm" and "nucleus", or with S100 cytosolic extracts, the particular enrichments of factory fractions are revealed (Fig. 5d) . fraction, as well as the cytoplasmic, nuclear, and nucleolar fractions, plus those in S100 cytosolic extracts. All data for panels a-d were generated using HeLa cells, and have been adapted by permission from ref. 8 . This is a cell type-specific effect and can be aggravated by DNA leakage.
TABLES
Optimize detergent concentration and treatment times for each cell type. Dilute nuclei into larger volumes; add PB to the nuclei in a stepwise manner.
7
Poor DNase I digestion. The coating of cell culture containers, or the brand of DNAse I used.
We have observed that DNases I from different manufacturers display variable cutting efficiencies when treating cells grown on coated cell-culture containers (e.g., mouse ES cells on gelatin-coated plates); here, trypsinization is preferred to scraping and cells should then be washed twice in PB.
The recommended DNase I shows robust digestion across conditions. DNase I performance is also pHdependent, and can be inefficient if the PB buffer has a pH even slightly higher than 7.4.
14 Very low yield in factory fraction.
